Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Fish and Richardson
Citi
Fuji
Chubb
Mallinckrodt
Farmers Insurance
Moodys
Express Scripts

Generated: September 18, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BUTORPHANOL TARTRATE

« Back to Dashboard

Clinical Trials for Butorphanol Tartrate

Trial ID Title Status Sponsor Phase Summary
NCT02715154 Dexmedetomidine for Cesarean Section Completed The First Affiliated Hospital with Nanjing Medical University Phase 1 Current cesarean section often chooses spinal anesthesia. And in order to avoid the impact of drugs on the fetus, before the delivery, anesthesiologist generally don't use sedative or analgesic drugs. However, the majority of puerperas would appear nervous, anxiety, fear and other psychological reactions in cesarean section. Although the placental transfer and the foetal metabolism of dexmedetomidine have been reported and the result show no adverse effects on neonates, but the placental transfer of dexmedetomidine in intravertebral anesthesia area was lack of systematical research. This study intends to use of dexmedetomidine in the cesarean section under epidural anesthesia and investigate its effects on the parturients' haemodynamics and the neonates' placental transfer and metabolism.
NCT03065530 Intravenous Dexmedetomidine for Cesarean Section Completed The First Affiliated Hospital with Nanjing Medical University Phase 4 Nervous, anxiety, fear and other psychological reactions always appears in parturients during cesarean section. This study intends to investigate the effectiveness and safety of dexmedetomidine combined with butorphanol tartrate for postoperative analgesia and breastfeeding after caesarean section.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Butorphanol Tartrate

Condition Name

Condition Name for Butorphanol Tartrate
Intervention Trials
Cesarean Section, Affecting Fetus or Newborn 1
Breast Feeding 1
Analgesia Obstetrical 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Butorphanol Tartrate
Intervention Trials
Pain, Postoperative 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Butorphanol Tartrate

Trials by Country

Trials by Country for Butorphanol Tartrate
Location Trials
China 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Butorphanol Tartrate

Clinical Trial Phase

Clinical Trial Phase for Butorphanol Tartrate
Clinical Trial Phase Trials
Phase 4 1
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Butorphanol Tartrate
Clinical Trial Phase Trials
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Butorphanol Tartrate

Sponsor Name

Sponsor Name for Butorphanol Tartrate
Sponsor Trials
The First Affiliated Hospital with Nanjing Medical University 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Butorphanol Tartrate
Sponsor Trials
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
McKesson
Merck
Daiichi Sankyo
Cantor Fitzgerald
US Department of Justice
Fish and Richardson
Fuji
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.